BMS associated with lower all-cause mortality compared with GLP-1RA treatmentBariatric metabolic surgery (BMS) was associated with lower all-cause mortality compared with glucagon-like peptide-1 receptor agonists...
BMS associated with lower all-cause mortality compared with GLP-1RA treatmentBariatric metabolic surgery (BMS) was associated with lower all-cause mortality compared with glucagon-like peptide-1 receptor agonists...
Allurion balloon results in 22.1% weight loss at one yearAllurion Technologies has revealed data from a study of 121 patients across 11 obesity centres treated with two consecutive, four-month...
Pre-operative use of GLP-1s may reduce post-bariatric complicationsA combination of GLP-1 agonists taken before metabolic and bariatric surgery may help patients with extreme obesity lower the risk of...
Flagship Pioneering, ProFound Therapeutics and Pfizer to identify novel first-in-class therapeutics for the treatment of obesityFlagship Pioneering and ProFound Therapeutics have entered a collaboration to conduct foundational research to identify potential...
Palatin initiates study of bremelanotide for the treatment of obesityPalatin Technologies has begun a Phase 2 clinical study of bremelanotide for the treatment of obesity. The clinical study will evaluate...
Long-term effectiveness of gastric bypass in treating type 2 diabetes and obesityRoux-en-Y gastric bypass kept type 2 diabetes in remission for up to 15 years and most of the weight off for up to 20 years in one of the...
MBS more effective and durable than new AOMs and lifestyle interventionSystematic reviews of medical literature between 2020 and 2024 show that bariatric and metabolic surgery produces the greatest and most...
MBS prevents pre-diabetes from developing into T2DM in most patientsPatients with pre-diabetes and severe obesity who had metabolic and bariatric surgery were 20 times less likely to develop full-blown...
Benefits of total robotic metabolic and bariatric surgery over conventional laparoscopyTwo new studies presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting suggest that...
Sleeve gastrectomy improves disease-specific outcomes in patients with inflammatory bowel diseaseSleeve gastrectomy - but not Roux-en-Y gastric bypass - was associated with improved disease-specific outcomes in patients with...
Journal Watch 12/06/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Tirzepatide was superior to placebo for MASH resolutionResults from Eli Lilly and Company’s SYNERGY-NASH that evaluated the investigational use of tirzepatide in adults with biopsy-proven...
BMS associated with lower all-cause mortality compared with GLP-1RA treatmentBariatric metabolic surgery (BMS) was associated with lower all-cause mortality compared with glucagon-like peptide-1 receptor agonists...